GENFIT
Desconocido
LITMUS: Liver Investigation Testing Marker Utility in Steatohepatitis
GENFIT
participó en un
H2020:
H2020-JTI-IMI2-2016-09-two-stage
Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, Non-Alcoholic Fatty Liv...
2017-10-09 - 2024-02-29 | Financiado
2017-10-09 - 2024-02-29 | Financiado
TOBI: Targeting OBesity driven Inflammation
GENFIT
participó en un
FP7:
The TOBI project aims to analyse mechanisms provoking adipokine-mediated crosstalk and an inflammatory drift in obese patients. It will be t...
Financiado
Financiado
* No se disponen de datos de la empresa actual.